Rahul Mathur
Analyst · Wells Fargo. You may now ask your question
Thanks, Luc. I’d like to begin with our financial results for the fourth quarter and for 2020. Let me start with some highlights of on slide five. As Luc mentioned, we delivered a solid quarter and are very pleased with the ongoing execution on our strategic initiatives. Once again, in Q4, we delivered financial results in line with our revenue expectations and at the high end of our earnings expectations. We had great financial results in 2020 and ended the year very well-positioned, as we continue to make progress on our long-term growth strategy. This performance was coupled with continual improvement in our balance sheet. We ended the year with $502.6 million in cash after implementing the $50 million share repurchase program in Q4. Our continued execution on our strategy and our operational discipline has yielded solid financial results and a strong balance sheet that affords us the flexibility to support our strategic initiative. We are focused on the compelling data center and cloud market opportunity in front of us, and are well-positioned for profitable growth in 2021 and beyond. Now let me talk you through some revenue details on slide six. Revenue for the fourth quarter was $61.9 million in line with our expected range. Royalty revenue was $27.7 million, while licensing and billings was $64.2 million. The difference between licensing billings and royalty revenue primarily relates to timing, as we don’t always recognize revenue in the same quarter we bill our customers. Going into additional detail, our product revenue was $21.8 million, consisting primarily of our buffer chip business. Our contract and other revenue was $12.4 million consisting primarily of our Silicon IP business. For the year there is roughly $40 million of our Silicon IP business that has been reflected in our license and billings. This is almost twice what we expected at our Analyst Day in 2019. Strength across our IP business enabled us to meet our revenue expectations in Q4. Multiple revenue streams enable us to offset quarterly variances in any particular business. We had a strong fiscal year. We are pleased with our execution and saw product revenue increased 56% significantly outpacing the market as we continue to gain share. Notably, we made these gains while also improving our margins and generating cash. Let me walk you through our non-GAAP income statement on slide seven. We again exceeded our profitability targets as we have done consistently over the past many years. Total operating expenses including COGS for the quarter came in at $55.8 million. Operating expenses of $46.7 million were lower than our expectations due to our continued focus on operational efficiency. We ended the quarter with headcount at 623, lower than in 679 in the previous quarter, as we continue to align our product programs with growth markets. Under ASC 606, we recorded $2.9 million of interest income related to the financing components of our fixed fee licensing arrangements through which we have recognized revenue but not yet received a payment. We incurred $0.6 million of interest expense, primarily associated with our convertible notes. This was offset by incremental interest income related to the return on our cash and investment portfolio. After adjusting for non-cash interest expense on our convertible notes, this resulted in non-GAAP interest and other income for the fourth quarter of $2.3 million. Excluding the interest income related to the significant financing component related to ASC 606, this would have been $0.6 million of interest and other expense. Using an assumed flat rate of 24% for non-GAAP pretax income, non-GAAP net income for the quarter was $6.4 million. With continued focus on cost and disciplined execution we delivered profit that was nicely above our expectations. Our financial results for 2020 are substantially better than what we expected at 2019s Analyst Day, despite the unprecedented challenges presented by COVID 19. We are delighted by the continued execution from our team. Now let me turn to the balance sheet details on slide eight. Over the past several years we have built a very strong balance sheet. Cash, cash equivalents and marketable securities totaled $502.6 million, down from the previous quarter as cash from operations of $42.1 million was offset by the $50 million accelerated share repurchase program we announced in Q4. This brings year-to-date cash from operations to $185.5 million, well above last year’s full year total of $128.5 million. Even with $23 million of capital expenditure related to our new headquarter facility, free cash flow of $142.5 million was well above last year’s total of $113.7 million. As we continue to deliver on the topline and execute on operational efficiency, we expect to continue to deliver strong cash from operations in the future. At the end of Q4, we have contracted assets worth $368 million, which reflects the net present value of unbilled AR related to licensing arrangements for which the company has no future performance obligations. I expect this number to continue to trend down, as we have bill and collect for these contracts. It is important to note that this metric doesn’t represent the entire value of our existing licensing arrangement, as several customers have royalty-based agreements that allow us to recognize revenue each quarter. As we sign new agreements and renew others, we endeavor to transition renewals and extensions to variable agreements that could allow us to take revenue over time as opposed to upfront. As we announced previously, we were pleased to extend our existing licensing and with Micron in September at our existing financial terms. Including the agreement with CXMT announced in Q1 last year we announced two DRAM licensing agreements that extend beyond the next renewal dates for Samsung and SK Hynix. Our success in completing these contracts with both new and existing partners serves as the testament to the ongoing strength and relevance of our patent portfolio. Going forward, we expect to recognize $10 million of revenue related to the Micron licensing extension on a quarterly basis starting in the first quarter of 2021. Between this extension and continued buffer chip growth, our revenue is poised for strong growth in 2021. Fourth quarter CapEx was $13 million and depreciation was $6.8 million. We delivered $29.1 million of free cash in the quarter. Full year 2020 CapEx was $422.9 million, of which $23 million was related to our new headquarters building. Looking forward, I expect ‘21 -- 2021 CapEx to be less than $5 million as our spend will be offset by the refund of the tenant improving allowance related to our new headquarters. I also expect depreciation of roughly $20 million for full year of 2021. Now, let me turn to our guidance for the first quarter on slide nine. As a reminder, our forward-looking guidance reflects our current assessment and actual results could differ materially from what I am about to review. In addition to the financial outlook under ASC 606, we have also been providing information on licensing billings, which is an operational metric that reflects amounts invoiced to our licensing customers during the period adjusted for certain differences. As you see in the supplemental information we provided on slide 13 of our earnings deck, licensing billings closely correlates with what we would historically reported as royalty revenue under ASC 605. Under ASC 606, we expect revenue in the first quarter between $63 million to $69 million. We expect royalty revenue between $23 million and $29 million. We also expect licensing billings between $60 million and $66 million. Our guidance reflects the contract term for the patent licensing extension with Micron, I mentioned previously, as royalty expectation we will see a return to normal buffer chip inventory consumption levels in the spring with sequential growth projected thereafter. We expect Q1 non-GAAP total operating cost and expenses, which includes COGS to be between $51 million and $57 million as we continue to invest in programs. Under ASC 606, non-GAAP operating results for the first quarter is expected to be between $2 million and $12 million profit. For non-GAAP interest and other income and expense, which exclude interest income related to ASC 606, we expected to be approximately $1 million of expense, which includes $0.6 million of interest expense related to the notes due in 2023. We expect our pro forma tax rate to remain consistent at roughly 24%. The 24% is higher than the statutory rate of 1%, primarily due to the higher tax rates in our foreign jurisdictions. As a reminder, we pay roughly $20 million of cash tax each year driven primarily by licensing agreements with our partners in Korea. We expect non-GAAP taxes to be between an expense of zero and $3 million in Q1. We expect our Q1 share count to be $116 million basic and diluted shares outstanding. This leads you to between a non-GAAP profitable share of $1 and $0.07 for the quarter. With that said, while we don’t provide guidance beyond Q1, we are comfortable with the analysts’ consensus estimates at the topline and bottomline for each quarter of 2021. While the near-term macroeconomic conditions are difficult for any of us to predict, consensus estimate are currently in line with our long-term strategy in current reception, reflecting our belief, we will continue to gain share and our product growth will continue to outpace broader semiconductor industry. Let me finish with a summary on slide 10. We are proud of the excellent performance by our team in this unpredictable macroeconomic environment. Over the past several years, we have made substantial progress strategically, operationally and financially. We have realigned our portfolio to address the data center and cloud opportunity, and support our long-term growth strategy, while consistently improving our balance sheet, generating cash and delivering value to our shareholders. Our 2020 results represent the beginning of the actual growth we expect to see in the coming years. Before I open up the call for Q&A, I would once again like to thank our employees for their continued teamwork and execution resilience during these uncertain times. Everyone, please stay safe and take care of yourself and your families. With that, I will turn the call back to our Operator to begin Q&A. Could we please have our first question?